North America Cardiac Resynchronisation Therapy Market Driven by Growing Heart Failure Prevalence
The Cardiac Resynchronisation Therapy Market in North America is witnessing steady growth due to the rising burden of heart failure and cardiovascular diseases and the increasing adoption of advanced implantable cardiac devices. Strong healthcare infrastructure, established cardiac-care facilities, growing availability of electrophysiology services, and increasing awareness of...
0 Comments 0 Shares 112 Views 0 Reviews